Changes of urinary dopamine excretion early after balloon mitral commissurotomy in mitral stenosis

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 8, 1999, Pages 634-638

  Hayashi, Manabu ^a   Takizawa, Hideki ^a   Tsuchihashi, Kazufumi ^a   Ura, Nobuyuki ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Congestive heart failure; Mitral stenosis; Percutaneous transvenous mitral commissurotomy; Urinary dopamine excretion

Indexed keywords

DOPAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DOPAMINE METABOLISM; DOPAMINE URINE LEVEL; DOPAMINERGIC SYSTEM; DRUG CLEARANCE; FEMALE; FLUID BALANCE; HEART INDEX; HUMAN; KIDNEY BLOOD FLOW; KIDNEY PROXIMAL TUBULE; MALE; MITRAL VALVE COMMISSUROTOMY; MITRAL VALVE STENOSIS; SODIUM RETENTION; URINARY EXCRETION;

EID: 0032770798     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03097.x     Document Type: Article

References (25)

1. Kuchel O, Cuche JL, Buu NT et al. Catecholamines excretion in 'idiopathic' edema: Decreased dopamine excretion, a pathogenic factor? J. Clin. Endocrinol. Metab. 1977; 44: 639-46.
2. Timura O, Yamaji I, Kikuchi K et al. The pathophysiological role of renal dopaminergic activity in patients with essential hypertension. Jpn. Circ. J. 1987; 51: 1232-40.
3. Hayashi M, Yamaji Y, Kitajima T. Aromatic L-amino-acid decarboxylase activity among rat nephrone. Am. J. Physiol. 1988; 254: F28-33.
4. + -ATPase activity is inhibited during high-salt diet: Evidence for DA-mediated effect. Am. J. Physiol, 1988; 254: F795-801.
5. Jose PA, Raymond MD, Bates A. The renal dopamine receptors. J. Am. Soc. Nephrol. 1992; 2: 1265-78.
6. Wolfovitz E, Grossman E, Folio C et al. Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans. Clin. Sci. 1993; 84: 549-57.
7. Lee MR. Dopamine and the kidney: Ten years on. Clin. Sci. 1993; 84: 357-75.
8. Hayashi M, Shimamoto K, Tsuchihashi K et al. Role of renal dopaminergic activity on renal sodium-water metabolism in congestive heart failure. Clin. Exp. Pharmacol. Physiol 1996; 23: 874-7.
9. Inoue K, Owaki T, Nakamura T et al. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J. Thorac. Cardiovasc. Surg. 1984; 87: 394-402.
10. Inoue K, Hung JS. Percutaneous, transvenous mitral commissurotomy (PTMC): The far east experience. In: Topol EJ (ed.). Interventional Cardiology. WB Saunders, Philadelphia. 1990; 887-99.
11. Ishikura F, Nagata S, Hirata Y et al. Rapid reduction of plasma atrial natriuretic peptide levels during percutaneous transvenous mitral commissurotomy in patients with mitral stenosis. Circulation 1989; 79: 47-50.
12. Tsuchihashi K, Sawai N, Takizawa H et al. Plasma noradrenaline as an indicator of functional state in hearts with mitral stenosis: The influence of acutely reduced left atrial pressure by balloon mitral commissurotomy. Heart Vessels 1993; 8: 85-90.
13. Kissinger PT, Riggin RM, Alcom RI, Rau LD. Estimation of catecholamines in urine by high performance liquid chromatography with electrochemical detection. Biochem. Med. 1975; 13: 299-306.
14. Moyer TP, Jiang NS, Tyce GM, Sheps SG. Analysis for urinary catecholamines by liquid chromatography with amperometric detection: methodology and clinical interpretation of results. Clin. Chem. 1979; 25: 256-63.
15. Cody RJ, Lungman S, Covit AB et al. Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int. 1988; 34: 361-7.
16. Lokhandwala MF, Amenta F. Anatomical distribution and function of dopamine receptors in the kidney. FASEB J. 1991; 5: 3023-30.
17. Segers O, Gerlo E, Dupont AG, Somers G. Decreased urinary dopamine excretion and disturbed dopamine/sodium relationship in type I diabetes mellitus. Diabet. Med. 1995; 12: 229-34.
18. Asakura S, Tabci K, Muto S et al. The role of endogenous dopamine in congestive heart failure. Jpn. Heart. J. 1989; 30: 115-27.
19. Kuchel O, Shigetomi S. Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients. Hypertension 1992; 19: 634-8.
20. Fernandes MH, Soares-da-Silva P. Role of monoamine oxidase and catechol-O-methyltransferase in the metabolism of renal dopamine. J. Neural. Transm. 1994; 41 (Suppl.): 101-5.
21. Pestana M, Faria MS, Oliveria JG et al. Assessment of renal dopaminergic system activity during the recovery of renal function in human kidney transplant recipients. Nephrol. Dial. Transplant. 1997; 12: 2667-72.
22. Aperia A, Eklof AC, Holtback U et al. The renal dopamine system. Adv. Pharmacol. 1998; 42: 870-3.
23. Eldrup E, Richter EA, Christensen NJ. DOPA, norepinephrine, and dopamine in rat tissues: No effect of sympathectomy on muscle DOPA. Am. J. Physiol. 1989; 256: E284-7.
24. Grossman E, Hoffman A, Armando I et al. Sympathoadrenal contribution to plasma dopa (3,4-dihydroxyphenylalanine) in rats. Clin. Sci. 1992; 83: 65-74.
25. Ibarra FR, Aguirre J, Nowicki S et al. Demethylation of 3-O-methyldopa in the kidney: A possible source for dopamine in urine. Am. J. Physiol, 1996; 270: 862-8.